iOnco

CoQ10 / Ubiquinol

Ubiquinol (mitochondrial co-enzyme)

Mitochondrial supportmoderate evidence

CoQ10/Ubiquinol is essential for mitochondrial ATP production and is a potent lipid-soluble antioxidant. Cancer patients are frequently deficient. Clinical studies show CoQ10 reduces cardiotoxicity from doxorubicin chemotherapy. Some integrative oncologists have documented tumour regression in patients taking high-dose CoQ10 (390 mg+/day) alongside standard treatment.

Medicinal Properties

Mitochondrial supportCardioprotectiveAntioxidantAnti-tumourAnti-fatigue
🎗️

Cancer Types Studied

BreastProstateColon

Recommended Dosage

100–600 mg ubiquinol (reduced CoQ10) daily with fatty meal.

Preparations

Ubiquinol Softgels

100–300 mg ubiquinol (not ubiquinone) daily with fatty meal. Ubiquinol is 8x more bioavailable than ubiquinone after age 40.

NIH / PubMed Research

Links open on PubMed (National Library of Medicine). Research is ongoing — results may not reflect clinical use.

Cautions & Interactions

  • May reduce warfarin effectiveness
  • Very safe — no significant toxicity even at high doses
  • Use ubiquinol form over age 40
  • May lower blood pressure

Informational only. Not medical advice. Consult your healthcare provider before use.